Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pioneering microbiome upstart Seres Therapeutics targets a $100M IPO
Pioneering microbiome upstart Seres Therapeutics targets a $100M IPO
Pioneering microbiome upstart Seres Therapeutics targets a $100M IPO
Submitted by
admin
on May 28, 2015 - 9:44am
Source:
Fierce Biotech
News Tags:
IPOs
Seres Therapeutics
Headline:
Pioneering microbiome upstart Seres Therapeutics targets a $100M IPO
Do Not Allow Advertisers to Use My Personal information
